Shares of cruise line stocks Carnival Corp. (CCL), Royal Caribbean (RCL), and Norwegian (NCLH) close lower on Tuesday as Morgan Stanley analysts slash their price targets, citing rising fuel costs in travel demand headwinds. Recently spun-off companies Vestis Corporation (VSTS), Veralto (VLTO), and WK Kellogg Co. (KLG) slide lower following their listing debuts. Lastly, pharmaceutical giant Eli Lilly (LLY) is set to acquire Point Biopharma (PNT) in a $1.4 billion deal. Yahoo Finance Live takes a closer look at several of Tuesday's trending stocks after the closing bell from the New York Stock Exchange. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
) close lower on Tuesday as Morgan Stanley analysts slash their price targets, citing rising fuel costs in travel demand headwinds.
Top TSX energy stocks such as Suncor Energy should be on your shopping list as crude oil prices remain elevated in 2023. The post Oil Prices Are Rising: Here Are the Enegy Stocks That Will Benefit the Most appeared first on The Motley Fool Canada.Cheap TSX stocks such as Dentalcorp are trading at an enticing valuation and have massive upside potential right now. The post 2 Defensive Stocks That Can Gain up to 128%, According to Bay Street appeared first on The Motley Fool Canada.
While mega-cap tech stocks are the cheapest since 2017, the upcoming earnings season is a catalyst for further growth, Goldman Sachs wrote.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
U.S. FDA declines to approve Eli Lilly's skin disease drug(Reuters) - The U.S. Food and Drug Administration has declined to approve Eli Lilly's drug to treat a type of skin disease due to certain findings ...
Lire la suite »
U.S. FDA declines to approve Eli Lilly's skin disease drug(Reuters) - The U.S. Food and Drug Administration has declined to approve Eli Lilly's drug to treat a type of skin disease due to certain findings ...
Lire la suite »
Lilly to Pay $1.4 Billion for Cancer-Drug Maker Point BiopharmaEli Lilly & Co. said it will pay about $1.4 billion to acquire Point Biopharma Global Inc. to gain radiation therapies in development for illnesses such as prostate cancer.
Lire la suite »
Traders Gain 1000% in a Day on Timely Point Biopharma Option BetA well-timed options trade in Point Biopharma Global Inc. stands to hand some investors upwards of $500,000 after Eli Lilly & Co.’s agreement to acquire the company sent its stock surging.
Lire la suite »
China Evergrande shares set to resume trade on Tuesday(Reuters) -China Evergrande Group said on Monday it has applied to the Hong Kong Stock Exchange for trading in its shares to resume on Tuesday, adding ...
Lire la suite »